Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms PROTAC 9 |
Target |
Mechanism BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC55H66ClN7O9S |
InChIKeyFYSWLIFIYIVHPI-DDWISSAJSA-N |
CAS Registry2010159-47-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | GB | 08 Jun 2017 | |
Hematologic Neoplasms | Preclinical | US | 08 Jun 2017 | |
Solid tumor | Preclinical | GB | 08 Jun 2017 | |
Solid tumor | Preclinical | US | 08 Jun 2017 |